The Woolcock Institute of Medical Research

A combination inhaled treatment, that is currently able to be prescribed for people with moderate-severe asthma, was recently registered for adults and adolescents with milder asthma. This follows the results of large studies showing that this treatment reduces the risk of serious flare-ups in people with mild or infrequent asthma symptoms.

Globally, an estimated 339 million people are living with asthma. In Australia, the prevalence of asthma is considered high, with 2.7 million people living with the condition. One million of these Australians have a mild form of the disease.

Click play to view the full story with Professor Helen Reddel from the Woolcock Institute, who has been closely involved in studies of treatment options for mild asthma.